@article{c997cdc6344e46359f31fbe3ad450f17,
title = "Screening and Surveillance of Hepatocellular Carcinoma: An Introduction to Ultrasound Liver Imaging Reporting and Data System",
abstract = "Given the high prevalence, increasing incidence, and significant morbidity and mortality related to hepatocellular carcinoma (HCC), a robust and cost-effective screening and surveillance program is needed. Most societies recommend ultrasound for HCC screening, despite lack of standardization in imaging acquisition, reporting content and language, and follow-up recommendations. The American College of Radiology Ultrasound Liver Imaging Reporting and Data System (US LI-RADS) fills this unmet need by providing standardization in the use of US in at-risk patients. It is anticipated that US LI-RADS will improve the performance of ultrasound for HCC screening and surveillance and unify management recommendations.",
keywords = "HCC, Hepatocellular carcinoma, Reporting, Screening, Surveillance, Ultrasound",
author = "Fetzer, {David T.} and Rodgers, {Shuchi K.} and Harris, {Alison C.} and Yuko Kono and Wasnik, {Ashish P.} and Aya Kamaya and Claude Sirlin",
note = "Funding Information: Disclosures: No author reports relevant commercial or financial conflicts of interest related to the content of this article. The authors disclose the following: speaking and research agreements with Philips Healthcare (D.T. Fetzer); receives royalties from Elsevier (A. Kamaya); industry research grants from Bayer, Guerbet, Siemens, GE, Supersonic, Arterys; research laboratory service agreements with Alexion, AstraZeneca, Bioclinica, BMS, Bracco, Celgene, Fibrogen, Galmed, Genentech, Genzyme, Gilead, Icon, Intercept, Isis, Janssen, NuSirt, Perspectum, Pfizer, Profil, Sanofi, Shire, Synageva, Tobira, Takeda, Virtual Scopics (C. Sirlin). Funding Information: Disclosures: No author reports relevant commercial or financial conflicts of interest related to the content of this article. The authors disclose the following: speaking and research agreements with Philips Healthcare (D.T. Fetzer); receives royalties from Elsevier (A. Kamaya); industry research grants from Bayer , Guerbet , Siemens , GE , Supersonic , Arterys ; research laboratory service agreements with Alexion, AstraZeneca, Bioclinica, BMS, Bracco, Celgene, Fibrogen, Galmed, Genentech, Genzyme, Gilead, Icon, Intercept, Isis, Janssen, NuSirt, Perspectum, Pfizer, Profil, Sanofi, Shire, Synageva, Tobira, Takeda, Virtual Scopics (C. Sirlin). Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",
year = "2017",
month = nov,
doi = "10.1016/j.rcl.2017.06.012",
language = "English (US)",
volume = "55",
pages = "1197--1209",
journal = "Radiologic Clinics of North America",
issn = "0033-8389",
publisher = "W.B. Saunders Ltd",
number = "6",
}